BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03660826-completion@plaintrial.com
DTSTAMP:20261027T094533Z
DTSTART;VALUE=DATE:20270121
SUMMARY:Testing the Combination of Olaparib and Durvalumab\, Cediranib and 
 Durvalumab\, Olaparib and Capivasertib\, and Cediranib Alone in Recurrent 
 or Refractory Endometrial Cancer Following the Earlier Phase of the Study 
 That Tested Olaparib and Cediranib in Comparison to Cediranib Alone\, and 
 Olaparib Alone — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03660826
URL:https://plaintrial.com/trial/NCT03660826
END:VEVENT
END:VCALENDAR